SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Oncology Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by T Vu, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by T Vu, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Standardization of body surface area calculations

Thanh T Vu, BSc(Pharm)

Pharmacy Department, Cross Cancer Institute, Edmonton, Alberta, Canada

Purpose. Antineoplastic agents have a narrow therapeutic index and therefore require the greatest degree of dose individualization. In choosing a body surface area (BSA) for‘mula, the challenge remains in obtaining consensus among prescribers. The objective of this review is to assess the various formulae available for calculating BSA and to adopt a standard formula within an institution.

Methods. Retrospective review of medication orders containing the patient’s height and weight as well as BSA calculated by the outpatient clinic staff within the Cross Cancer Institute (CCI) from 7 to 15 July 1998. Four BSA calculating devices, in current use by the clinical staff, were also tested to determine the formula currently utilized by prescribers.

Results. Thirty-three orders sent to the pharmacy containing the patient’s height, weight, and BSA were reviewed. Ninety-four per cent of the BSA calculated by the clinic staff differed from pharmacy’s calculations by 0% to 4%. One BSA calculation differed by 8% and another differed by 14%. With respect to the available BSA calculating devices, all appeared to be based on the Du Bois formula.

Conclusion. Of the various formulae available for estimating BSA, we concluded that the Mosteller equation is the most acceptable based on both BSA calculation accuracy and ease of use. Based on this determination, the CCI approved the adoption of the Mosteller equation as the institutional standard. This equation was later standardized throughout the entire Alberta Cancer Board. Other methods of dose determination are emerging, including therapeutic drug monitoring and PMT dosing. Further investigation is required as to whether these methods will lead to better standardization of dose.

Key Words: body surface area • BSA formula • chemotherapy dosing • dose calculations

Journal of Oncology Pharmacy Practice, Vol. 8, No. 2-3, 49-54 (2002)
DOI: 10.1191/1078155202jp095oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Oncol Pharm PractHome page
M. J Dooley and S. G Poole
Letter to the Editor
Journal of Oncology Pharmacy Practice, March 1, 2003; 9(1): 43 - 43.
[PDF]



Advertisement